Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Neurofibromin/dopamine signaling as a biomarker for cognitive and behavioral problems in children with neurofibromatosis type 1 (NF1 )

Neurofibromin/dopamine signaling as a biomarker for cognitive and behavioral problems in children with neurofibromatosis type 1 (NF1 )

US Patent 11085933 · Granted Aug 10, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating cancer using neuronal activity inhibiting agents2025
Methods of treating cancer using neuronal activity inhibiting agents2025
Neurofibromin pathway modulators2012
Neurofibromatosis gene2001
Neurofibromatosis gene1999